Fortitude Family Office, LLC

Family Office

Position in ABBV — AbbVie Inc.

CIK 1950506 SCOTTSDALE, AZ

Position in ABBV

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$1,063,179

+$138,630 QoQ

Shares Held

4,225

-0.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.08%

of 13F equity value

Holder Rank

#2,479

of 4,153 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fortitude Family Office, LLC holds $6,252,480 across 11 Drug Manufacturers - General names. ABBV ranks #2 (17.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,046	$3,653,464
2	ABBV	AbbVie Inc. This page	4,225	$1,063,179
3	JNJ	Johnson & Johnson	1,844	$468,320
4	AMGN	Amgen Inc	1,172	$424,404
5	MRK	Merck & Co., Inc.	2,950	$379,075
6	GILD	Gilead Sciences, Inc.	690	$87,174
7	BMY	Bristol Myers Squibb Co	1,205	$69,432
8	BIIB	Biogen Inc.	315	$68,058

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,063,179	4,225	-0.6%	Shares	Sole	2026-07-20
2026-03-31	$924,549	4,251	-22.8%	Shares	Sole	2026-04-16
2025-12-31	$1,258,522	5,508	-0.6%	Shares	Sole	2026-01-15
2025-09-30	$1,283,657	5,544	-6.5%	Shares	Sole	2025-10-17
2025-06-30	$1,100,726	5,930	-22.5%	Shares	Sole	2025-07-15
2025-03-31	$1,602,199	7,647	-26.1%	Shares	Sole	2025-04-16
2024-12-31	$1,839,195	10,350	+0.9%	Shares	Sole	2025-01-10
2024-09-30	$2,025,947	10,259	+150.4%	Shares	Sole	2024-10-25
2024-06-30	$702,717	4,097	+136.4%	Shares	Sole	2024-07-10
2024-03-31	$315,579	1,733	0.0%	Shares	Sole	2024-04-11
2023-12-31	$268,563	1,733	—	Shares	Sole	2024-01-12
No filing history on record for this holder in this stock.